Koers InNexus Biotechnology, Inc. Other OTC
Aandelen
IXSBF
CA45771Q1046
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | - | Marktkapitalisatie | 2,89 mln. 2,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | -8 mln. -7,45 mln. | Nettowinst (verlies) 2010 | -6 mln. -5,59 mln. | EV/omzet 2009 | - |
Nettoschuld 2009 | 3,35 mln. 3,12 mln. | Nettoschuld 2010 | 5,64 mln. 5,25 mln. | EV/omzet 2010 | - |
K/w-verhouding 2009 |
-0,92
x | K/w-verhouding 2010 |
-0,36
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 92,4% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,03% | 125 mld. | |
+13,14% | 108 mld. | |
-7,46% | 24,21 mld. | |
+2,15% | 22,78 mld. | |
-10,79% | 17,96 mld. | |
-41,74% | 16,43 mld. | |
-12,64% | 16,37 mld. | |
+1,03% | 13,58 mld. | |
+26,70% | 11,66 mld. |